Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has provided an update.
WuXi AppTec Co., Ltd. has announced the grant of 27,274,870 H Share Awards under its 2024 H Share Award and Trust Scheme to 3,985 selected participants. This grant, representing approximately 7.0464% of the total issued H Shares, is aimed at incentivizing both connected and independent participants, without causing any dilution effect on existing shareholders. The board considers this grant to be fair and in the best interest of the company and its shareholders.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in China, operating in the pharmaceutical and biotechnology industry. The company provides a range of services including research, development, and manufacturing solutions, focusing on enabling global healthcare innovation.
Average Trading Volume: 8,758,998
Technical Sentiment Signal: Buy
Current Market Cap: HK$185.8B
See more insights into 2359 stock on TipRanks’ Stock Analysis page.